Allogeneic hematopoietic cell transplantation improves outcome in myelodysplastic syndrome across high-risk genetic subgroups: genetic analysis of the Blood and …
J Versluis, W Saber, HK Tsai, CJ Gibson… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Allogeneic hematopoietic cell transplantation (HCT) in patients with
myelodysplastic syndrome (MDS) improves overall survival (OS). We evaluated the impact …
myelodysplastic syndrome (MDS) improves overall survival (OS). We evaluated the impact …
[HTML][HTML] Outlier expression of isoforms by targeted or total RNA sequencing identifies clinically significant genomic variants in hematolymphoid tumors
Recognition of aberrant gene isoforms due to DNA events can impact risk stratification and
molecular classification of hematolymphoid tumors. In myelodysplastic syndromes, KMT2A …
molecular classification of hematolymphoid tumors. In myelodysplastic syndromes, KMT2A …
Targeting the deubiquitinase USP2 for malignant tumor therapy
S Zhang, Y Guo, S Zhang, Z Wang… - Oncology …, 2023 - spandidos-publications.com
The ubiquitin‑proteasome system is a major degradation pathway for> 80% of proteins in
vivo. Deubiquitylases, which remove ubiquitinated tags to stabilize substrate proteins, are …
vivo. Deubiquitylases, which remove ubiquitinated tags to stabilize substrate proteins, are …
[HTML][HTML] Characterizing the allele-specific gene expression landscape in high hyperdiploid acute lymphoblastic leukemia with BASE
J Andersson, E Aydın, R Gunnarsson, H Lilljebjörn… - Scientific Reports, 2024 - nature.com
Somatic copy number variations (CNVs), including abnormal chromosome numbers and
structural changes leading to gain or loss of genetic material, play a crucial role in initiation …
structural changes leading to gain or loss of genetic material, play a crucial role in initiation …
[HTML][HTML] Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia
BA Pitel, C Zepeda-Mendoza, Z Sachs, H Tang… - Blood cancer …, 2023 - nature.com
Dear Editors, Acute myeloid leukemia (AML) can be classified into multiple genetic subtypes
based on recurrent pathogenic structural variants (SVs), copy number abnormalities (CNAs) …
based on recurrent pathogenic structural variants (SVs), copy number abnormalities (CNAs) …
[HTML][HTML] Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia
A Seto, G Downs, O King, S Salehi-Rad, A Baptista… - Cancers, 2024 - mdpi.com
Simple Summary Genetic rearrangements of the KMT2A gene are associated with
diagnostic and prognostic outcomes in the context of myeloid neoplasms. While …
diagnostic and prognostic outcomes in the context of myeloid neoplasms. While …
[HTML][HTML] Predicting leukemic transformation in myelodysplastic syndrome using a transcriptomic signature
C Guo, YY Gao, ZL Li - Frontiers in Genetics, 2023 - frontiersin.org
Background: For prediction on leukemic transformation of MDS patients, emerging model
based on transcriptomic datasets, exhibited superior predictive power to traditional …
based on transcriptomic datasets, exhibited superior predictive power to traditional …
Outlier expression of isoforms by targeted RNA sequencing as clinical markers of genomic variants in B lymphoblastic leukemia and other tumor types
Recognition of aberrant gene isoforms indicative of underlying DNA events can impact
molecular classification and risk stratification of B lymphoblastic leukemia (B-ALL). Aberrant …
molecular classification and risk stratification of B lymphoblastic leukemia (B-ALL). Aberrant …
[HTML][HTML] Myeloid malignancies' driver mutations-Part# 2: KMT2A, a gene for epigenetic regulation
OGT All - Technology, 2023 - ogt.com
Myeloid malignancies are influenced by various genetic and epigenetic influences,
manifested by excessive proliferation, abnormal self-renewal, and/or differentiation defects …
manifested by excessive proliferation, abnormal self-renewal, and/or differentiation defects …
[HTML][HTML] Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation
J Ogino, Y Dou - Journal of Biological Chemistry, 2024 - Elsevier
Our current understanding of epigenetic regulation is deeply rooted in the founding
contributions of Dr. C. David Allis. In 2002, Allis and colleagues first characterized the lysine …
contributions of Dr. C. David Allis. In 2002, Allis and colleagues first characterized the lysine …